These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33242360)
21. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132 [TBL] [Abstract][Full Text] [Related]
22. Comparison of two primer-probe sets of Yamaoka Y; Sasai M; Suehiro Y; Hashimoto S; Goto A; Yamamoto N; Suzuki N; Higaki S; Fujii I; Suzuki C; Matsumoto T; Hoshida T; Koga M; Tsutsumi T; Lim LA; Matsubara Y; Tomochika S; Yoshida S; Hazama S; Yotsuyanagi H; Nagano H; Sakaida I; Takami T; Yamasaki T Ann Clin Biochem; 2022 Nov; 59(6):396-403. PubMed ID: 35821582 [TBL] [Abstract][Full Text] [Related]
23. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471 [TBL] [Abstract][Full Text] [Related]
24. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Yu J; Chen Y; Fu X; Zhou X; Peng Y; Shi L; Chen T; Wu Y Int J Cancer; 2016 Sep; 139(6):1318-26. PubMed ID: 27130618 [TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498 [TBL] [Abstract][Full Text] [Related]
26. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade. Chen Y; Peng Y; Yu J; Chen T; Wu Y; Shi L; Li Q; Wu J; Fu X Oncotarget; 2017 May; 8(19):31802-31814. PubMed ID: 28423670 [TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers. Chen Y; Lu Y; Ke Y; Li Y Medicine (Baltimore); 2019 Sep; 98(39):e17221. PubMed ID: 31574832 [TBL] [Abstract][Full Text] [Related]
28. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
35. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis. Wang WY; Zhou H; Wang Z; Zhang YH Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912 [TBL] [Abstract][Full Text] [Related]
36. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Wang N; Fang JY Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786 [TBL] [Abstract][Full Text] [Related]
37. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis. Liu W; Zhang X; Xu H; Li S; Lau HC; Chen Q; Zhang B; Zhao L; Chen H; Sung JJ; Yu J Gastroenterology; 2021 Jun; 160(7):2395-2408. PubMed ID: 33581124 [TBL] [Abstract][Full Text] [Related]
38. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer. Suraweera N; Mouradov D; Li S; Jorissen RN; Hampson D; Ghosh A; Sengupta N; Thaha M; Ahmed S; Kirwan M; Aleva F; Propper D; Feakins RM; Vulliamy T; Elwood NJ; Tian P; Ward RL; Hawkins NJ; Xu ZZ; Molloy PL; Jones IT; Croxford M; Gibbs P; Silver A; Sieber OM Oncotarget; 2016 Jun; 7(24):36474-36488. PubMed ID: 27167335 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of Yan X; Liu L; Li H; Qin H; Sun Z Onco Targets Ther; 2017; 10():5031-5046. PubMed ID: 29081665 [TBL] [Abstract][Full Text] [Related]
40. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]